非小细胞肺癌的非小细胞肺癌
Lizza E L Hendriks1, Jordi Remon2, Corinne Faivre-Finn3
1Department of Pulmonary Diseases, GROW-School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands.
Nature reviews. Disease primers
|September 26, 2024
概括
非小细胞肺癌 (NSCLC) 管理方面的进展,包括查,手术技术和向治疗,正在改善患者的治疗结果. 个性化治疗策略是NSCLC护理未来进展的关键.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 癌症研究 癌症研究
背景情况:
- 非小细胞肺癌 (NSCLC) 是全球癌症死亡的主要原因.
- 在过去的十年中,最近的进展显著改善了NSCLC的治疗和患者的预后.
- 改进的关键领域包括查,手术和放射治疗技术以及全身治疗.
研究的目的:
- 审查非小细胞肺癌管理的近期改进.
- 突出新策略对非转移性和转移性NSCLC患者结局的影响.
- 强调个性化治疗概念的未来方向.
主要方法:
- 审查最近的文献和NSCLC管理的临床进展.
- 分析系统查 (低剂量CT) 对早期检测的影响.
- 评估新的外科手术,放射治疗和全身治疗选择.
主要成果:
- 通过外科手术期间的策略和局部晚期疾病的辅助免疫疗法,改善非转移性NSCLC的治愈率.
- 通过新药的实施,在转移性NSCLC中长期控制疾病并保持生活质量.
- 在了解NSCLC生物学方面取得了显著进展,这导致了创新的全身疗法.
结论:
- 由于查,治疗方式和生物学理解的进步,NSCLC患者的预后得到了改善.
- 组合策略和新型药物为早期和高级NSCLC提供了更好的结果.
- 预测性临床和遗传标记的开发对于未来个性化NSCLC治疗至关重要.
更多相关视频
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.5K
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.3K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K